Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors

NCT06010862 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric Cancer
Colon Cancer
Pancreas Cancer
Esophagus Cancer
Cholangiocarcinoma
Lung Cancer
Breast Cancer

Interventions

BIOLOGICAL: CEA CAR-T cells
BIOLOGICAL: CEA CAR-T cells

Sponsor

Chongqing Precision Biotech Co., Ltd

Collaborators

[object Object]